Skip to main content
. 2017 Nov 23;50(6):149–158. doi: 10.1267/ahc.17015

Fig. 9.

Fig. 9.

Three consecutive sections of the stomach indicating effects of pre-absorption of anti-CXCL14 antibody used in this study with recombinant CXCL14 (A) and somatostatin (C). (B) Positive control. Arrows in A and B indicate the cells in which CXCL14-like immunoreactivity disappears following pre-absorption with recombinat CXCL14; arrowheads in B and C indicate the cells in which CXCL14-like immunoreactivity was not affected by pre-abosorption with somatostatin.